2011
May 23, 2013
FDA allows marketing of first A1c test labeled for diagnosing diabetes
Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals. This is the first HbA1c test ...
> more
 

Our goal is to partner with news reporters and provide relevant information that is of interest to various audiences. Media with questions related to Roche or its products may contact us at: 

 +1-317-521-2000

 

   email

 

 Roche US News

May 23, 2013
FDA approves Tarceva (erlotinib) tablets and cobas EGFR Mutation Test for specific type of lung cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Tarceva (erlotinib) tablets for the i...
> more

March 6, 2013
FDA approves new Roche test to evaluate response to hepatitis C therapy Viral load test uses a novel dual-probe approach designed to manage patients being treated with antiviral therapies
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the US Food and Drug Administration (FDA) for a next-generation ...
> more

January 17, 2013
Roche Diagnostics Named to FORTUNE magazine’s 2013 list of “100 Best Companies to Work For”
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche Diagnostics Corporation has been selected to FORTUNE magazine’s annual list of the “100 ...
> more

November 12, 2012
Roche launches additional test for improved management of epithelial ovarian cancer patients
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. market availability of the Elecsys HE4 assay, an FDA approved test used in monitoring pati...
> more

 Roche Global News
Retrieving Data